Ridgewood Investments LLC acquired a new position in shares of Petmed Express Inc (NASDAQ:PETS) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 22,281 shares of the company’s stock, valued at approximately $508,000. Ridgewood Investments LLC owned about 0.11% of Petmed Express as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. LSV Asset Management increased its holdings in Petmed Express by 624.1% during the 4th quarter. LSV Asset Management now owns 564,787 shares of the company’s stock valued at $13,136,000 after acquiring an additional 486,787 shares in the last quarter. River Road Asset Management LLC acquired a new position in Petmed Express in the fourth quarter worth $11,022,000. Epoch Investment Partners Inc. boosted its holdings in Petmed Express by 47.9% in the fourth quarter. Epoch Investment Partners Inc. now owns 1,268,358 shares of the company’s stock worth $29,502,000 after purchasing an additional 410,636 shares during the period. American Century Companies Inc. acquired a new position in Petmed Express in the fourth quarter worth $6,088,000. Finally, Deutsche Bank AG boosted its holdings in Petmed Express by 166.1% in the fourth quarter. Deutsche Bank AG now owns 329,962 shares of the company’s stock worth $7,673,000 after purchasing an additional 205,960 shares during the period. Institutional investors and hedge funds own 95.04% of the company’s stock.
Several equities research analysts recently weighed in on PETS shares. BidaskClub raised shares of Petmed Express from a “sell” rating to a “hold” rating in a report on Wednesday, January 16th. Craig Hallum cut their price objective on Petmed Express from $25.00 to $18.00 and set a “sell” rating on the stock in a report on Wednesday, January 23rd. Finally, ValuEngine downgraded Petmed Express from a “hold” rating to a “sell” rating in a report on Monday, February 4th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. Petmed Express presently has an average rating of “Hold” and an average target price of $28.00.
Petmed Express (NASDAQ:PETS) last announced its earnings results on Tuesday, January 22nd. The company reported $0.38 EPS for the quarter, missing the consensus estimate of $0.48 by ($0.10). The business had revenue of $60.10 million for the quarter, compared to the consensus estimate of $64.22 million. Petmed Express had a return on equity of 32.89% and a net margin of 14.43%. Petmed Express’s revenue for the quarter was up .0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.44 EPS.
Petmed Express Company Profile
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Featured Article: Risk Tolerance and Your Investment Decisions
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.